{
    "2018-03-22": [
        [
            {
                "time": "2018-03-22",
                "original_text": "今日资金抢入六只强势股一览",
                "features": {
                    "keywords": [
                        "资金",
                        "抢入",
                        "强势股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "股票市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-22",
                "original_text": "[买入评级]贝达药业(300558)：从1到N 从BIOTECH到PHARMACEUTICALS",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "买入评级",
                        "创新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-22",
                "original_text": "专访全国人大代表、贝达药业董事长丁列明： 改革药品市场准入， 让更多创新成果得到应用",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "丁列明",
                        "药品市场准入",
                        "创新成果"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "政策改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}